about
Prognostic value of NT-proBNP and an adapted monin score in patients with asymptomatic aortic stenosis.Real world heart failure epidemiology and outcome: A population-based analysis of 88,195 patients.Impact on clinical events and healthcare costs of adding telemedicine to multidisciplinary disease management programmes for heart failure: Results of a randomized controlled trial.No benefit from the obesity paradox for diabetic patients with heart failure.Medical resource use and expenditure in patients with chronic heart failure: a population-based analysis of 88 195 patients.Clinical characteristics, one-year change in ejection fraction and long-term outcomes in patients with heart failure with mid-range ejection fraction: a multicentre prospective observational study in Catalonia (Spain).Obstructive Sleep Apnea and Atherosclerosis: Both the Gut Microbiome and Hypercapnia Matter.Effect of Permanent Atrial Fibrillation on Cognitive Function in Patients With Chronic Heart Failure.Long-term outcome of transitory "reversible" complete atrio-ventricular block unrelated to myocardial ischemia.Iron Status in Chronic Heart Failure: Impact on Symptoms, Functional Class and Submaximal Exercise Capacity.Importance of iron deficiency in patients with chronic heart failure as a predictor of mortality and hospitalizations: insights from an observational cohort studyIndividual income, mortality and healthcare resource use in patients with chronic heart failure living in a universal healthcare system: A population-based study in Catalonia, SpainReduced levels of vasopressin, an independent mechanism in the obesity paradox in patients with chronic heart failure: Insights from the DAMOCLES studyAssociation Between Norepinephrine Levels and Abnormal Iron Status in Patients With Chronic Heart Failure: Is Iron Deficiency More Than a Comorbidity?In-hospital acquired anemia in acute coronary syndrome. Predictors, in-hospital prognosis and one-year mortalityDifferences in neurohormonal activity partially explain the obesity paradox in patients with heart failure: The role of sympathetic activationPrevalence and outcome of patients with left bundle branch block and suspected acute myocardial infarctionSleep and the Microbiome: A Two-Way RelationshipObstructive sleep apnoea and exercise functional capacity: time to move?Stromal cell derived factor-1 and long-term prognosis in acute coronary syndromeImpact of telemedicine on the clinical outcomes and healthcare costs of patients with chronic heart failure and mid-range or preserved ejection fraction managed in a multidisciplinary chronic heart failure programme: A sub-analysis of the iCOR randoEfficacy of a nurse-led lipid-lowering secondary prevention intervention in patients hospitalized for ischemic heart disease: A pilot randomized controlled trialManagement of Heart Failure with Reduced Ejection Fraction after ESC 2016 Heart Failure Guidelines: The Linx RegistrySurface respiratory electromyography and dyspnea in acute heart failure patients
P50
Q33164211-E2309565-8340-4E14-BDF4-D07C68C00992Q36290215-E93D1B02-9DEE-49EC-A184-50EDF2FABC58Q40561465-3473CE29-E2F3-4C82-AA35-ED4B22BBAA66Q40696102-0D3896B3-0EBC-49FA-BE01-259395C38A57Q40784558-EC3323DD-7B18-4181-8F95-2C1ACE932867Q47186244-E106B9BF-3E4F-4749-B1B8-41D5E9B9E3F2Q47667160-55B16447-5E1B-4A14-9D11-1839BACC8692Q49124829-D67ABB38-D015-42B1-A032-71308C9C59EFQ51116305-58B25A27-86B2-49D3-9726-283A42E5DD1FQ53243954-6469D2F9-71CC-4B0E-95A7-FD3E1AC02237Q58078885-CC1ABC00-6FC3-468E-B0FE-3F345A019DF5Q58584601-1D251B27-16EA-4BBA-9886-4B1FE2738BA8Q58597477-B5DCD0DE-1ECB-4FEE-9A04-94BE49126BF3Q64241834-6445648E-7B11-4191-BBD4-314151374B6BQ84400424-6490D959-A3DA-45EA-B238-7DACFBE01B9DQ86252998-02718C59-DC4D-4B0D-B81D-3D373D7CCF8AQ86507956-1D6B20FF-E4C5-4028-BEE8-A36256FB4089Q88865275-3AF299BA-474B-4BAE-9A73-C5C20CA4B41CQ89322341-CC6DBE98-A60F-4CF3-B555-F4AA8F3B0573Q90324151-593CE0D6-672B-44EA-9423-D690C36F0248Q91333508-30817FF3-266E-4046-8433-251806B8E2D3Q91535748-B8FC9827-6871-455C-99E9-26F48578E9BCQ92509907-6A4BDA11-8009-4273-9C1A-F7471841586AQ94457739-704CC795-92A4-4B78-80A0-F0B09E81B240
P50
description
researcher ORCID ID = 0000-0003-3110-6572
@en
wetenschapper
@nl
name
Nuria Farré
@ast
Nuria Farré
@en
Nuria Farré
@es
Nuria Farré
@nl
type
label
Nuria Farré
@ast
Nuria Farré
@en
Nuria Farré
@es
Nuria Farré
@nl
prefLabel
Nuria Farré
@ast
Nuria Farré
@en
Nuria Farré
@es
Nuria Farré
@nl
P108
P106
P21
P31
P496
0000-0003-3110-6572